High-quality oral anticoagulation management with warfarin requires optimizing parameters such as time in therapeutic range, therapy initiation, and perioperative dosing.
Thromboembolic disease requiring oral anticoagulation
Oral vitamin K antagonist therapy (warfarin)
Oral anticoagulation therapy with warfarin is the mainstay of prevention and treatment of thromboembolic disease. However, it remains one of the leading causes of harmful medication errors and medication-related adverse events. The beneficial outcomes of oral anticoagulation therapy are directly dependent upon the quality of dose and anticoagulation management, but the literature is not robust with regards to what constitutes such management. This review focuses on, and attempts to define, the parameters of high-quality anticoagulation management and identifies the appropriate outcome measures constituting high-quality management. Elements discussed include the most fundamental measure, time in therapeutic range, along with other parameters including therapy initiation, time to therapeutic range, dosing management when patients are not in therapeutic range, perioperative dosing management, patient education, and other important outcome measures. Healthcare providers who manage oral anticoagulation therapy should utilize these parameters as a measure of their performance in an effort to achieve high-quality anticoagulation management.
Building similarity graph...
Analyzing shared references across papers
Loading...
Katherine W. Phillips
University of Birmingham
Jack Ansell
Preventive Cardiology
Expert Review of Cardiovascular Therapy
Boston University
Building similarity graph...
Analyzing shared references across papers
Loading...
Phillips et al. (Thu,) conducted a review in Thromboembolic disease requiring oral anticoagulation. Oral vitamin K antagonist therapy (warfarin) was evaluated. High-quality oral anticoagulation management with warfarin requires optimizing parameters such as time in therapeutic range, therapy initiation, and perioperative dosing.
synapsesocial.com/papers/6a1c221d1567d2fc4d5fa519 — DOI: https://doi.org/10.1586/14779072.6.1.57